FAM177A1 Inhibits IL-1β-Induced Signaling by Impairing TRAF6-Ubc13 Association

J Immunol. 2021 Dec 15;207(12):3090-3097. doi: 10.4049/jimmunol.2100561. Epub 2021 Nov 19.

Abstract

The proinflammatory cytokine IL-1β is a crucial mediator of inflammatory responses. IL-1β-induced signaling is finely regulated by various mechanisms, and its imbalance is involved in a variety of diseases. In this study, we identified FAM177A1, a protein of unknown function, as a negative regulator of IL-1β-induced signaling in human cells. Overexpression of FAM177A1 inhibited IL-1β-triggered activation of NF-κB and transcription of inflammatory genes, whereas knockdown of FAM177A1 showed the opposite effects. Mechanistically, FAM177A1 competitively bound to the E3 ubiquitin ligase TRAF6 and impaired its interaction with the E2-conjugating enzyme Ubc13; therefore, it inhibited TRAF6-mediated polyubiquitination and recruitment of downstream signaling molecules. These findings reveal a function of FAM177A1 and promote our understanding of the regulatory mechanisms of IL-1β-induced inflammatory responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interleukin-1beta* / metabolism
  • NF-kappa B / metabolism
  • Signal Transduction* / physiology
  • TNF Receptor-Associated Factor 6* / metabolism
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitination

Substances

  • IL1B protein, human
  • Interleukin-1beta
  • NF-kappa B
  • TNF Receptor-Associated Factor 6
  • Ubiquitin-Protein Ligases
  • FAM177A1 protein, human